Table 2 Demographics of patients receiving SEMS placement
From: An outcome analysis of self-expandable metallic stents in central airway obstruction: a cohort study
|  | Total (n = 211) | Benign (n = 116) | Malignant (n = 95) | p value¶ |
|---|---|---|---|---|
Demography | ||||
   Age (yrs) | 61.2 ± 15.7 | 63.9 ± 15.6 | 58.0 ± 15.2 | 0.006 |
   Gender, Male, n(%) | 158(74.9) | 72(66.1%) | 86(90.5) | <. 0001 |
   Smoking, n(%) | 136(64.5) | 55(47.4) | 81(82.3) | <. 0001 |
   FEV1(L/s) | 1.05 ± 0.55 | 0.90 ± 0.40 | 1.47 ± 0.68 | <. 0001 |
   SEMS follow up days, median(IQR) | 130(39-550) | 429(141-856) | 57(19-103) | <. 0001 |
   Cover SEMS, n(%) | 132(62.6) | 42(36.2) | 90(94.7) | <. 0001 |
Clinical manifestation before SEMS implantation | ||||
   Dyspnoea, n(%) | 157(74.4) | 111(95.7) | 46(48.4) | <. 0001 |
   Cough, n(%) | 22(10.4) | 2(1.7) | 20(21.1) | <. 0001 |
   Respiratory failure, n(%) | 20(9.5) | 3(2.6) | 17(17.9) | .0002 |
   Pneumonia, n(%) | 9(4.3) | 0(0) | 9(9.5) | .0007 |
   Haemoptysis, n(%) | 3(1.4) | 0(0) | 3(3.2) | 0.05 |